Paul Steven ConynghamNews coverage
PYMNTSOne Dog’s Cancer Vaccine Just Became a Real Company
Discover more
GlobeNewswireOne dog's legacy becomes Gamgee
Company press releasePaul Steven Conyngham
KBS DocumentaryThe story reaches Korean national television
InGeNAFive things Rosie's story gets right about genomics and personalised medicine
VetlifeRosie and the mRNA Vaccine: The Real Story
NBC NewsThe man who used AI to design a cancer vaccine for his dying dog
CBS NewsPaul and Professor Thordarson on how the vaccine was made
The AustralianThe report that started it all
TODAYPaul and Rosie on the morning show sofa
Research & science
UNSW SydneyMeet the man who designed a cancer vaccine for his dog
Discover more
ACS Information AgeThe computational method, and a second vaccine in design
April 2026Cancer Health
Cancer HealthWhere Rosie's case sits in a decade of vaccine research
The ConversationAn oncologist on what a single case can and cannot prove
The ScientistInside the pipeline, from tumour sequencing to mRNA construct
In the conversation
SA
Sam Altman@sama
Sam AltmanFrom Rosie’s story to Gamgee
Discover more
Y CombinatorInput the tumor. Output the vaccine.
Launch post · LinkedIn
Y CombinatorFrom one dog to a repeatable clinical system
TechRadarTracking down the unnamed man in Altman's story
CNBC-TV18How Altman's post carried the story into Indian business media
Core Memory PodcastThe whole protocol, told without a broadcast clock
TBPN DigestA fact-check of the version that went viral
Hank GreenA science communicator separates the signal from the hype
Other coverage
Use Left and Right arrow keys to browse. Press Space to pause or resume automatic scrolling.
Latest publications
GlobeNewswireOne dog's legacy becomes Gamgee
Company press release
PYMNTSOne Dog’s Cancer Vaccine Just Became a Real Company
Y CombinatorInput the tumor. Output the vaccine.
Launch post · LinkedInY CombinatorFrom one dog to a repeatable clinical system
Paul Steven Conyngham